EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 3-Nov-2026 22:16 ET (4-Nov-2026 03:16 GMT/UTC)

Cell-preservation technique could make CAR-T cell therapy more accessible

Massachusetts Institute of Technology
Peer-Reviewed Publication

MIT researchers developed a way to protect CAR-T cells from damage that can occur when they are frozen for storage and shipment. Their technique should make it easier for more hospitals to provide this treatment option to cancer patients.

Journal: Trends in Biotechnology
Funder: Ludwig Center at MIT’s Koch Institute, Convergence Scholars Program, MIT Marble Center for Cancer Nanomedicine

Colon cancer: How highly aggressive tumors evade the immune system

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Peer-Reviewed Publication

Researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer evades the immune system. The findings show that the activation of a key signaling pathway helps cancer cells suppress the immune system, thereby promoting the development of malignant tumors.

Journal: Gastroenterology

Aging reprograms skin genetic activity and promotes inflammation

Institute for Research in Biomedicine (IRB Barcelona)
Peer-Reviewed Publication

Researchers at IRB Barcelona identify a molecular mechanism that amplifies chronic inflammation in aged skin.

With age, two proteins that normally help maintain epidermal function, BMAL1 and YAP, switch to promoting genes associated with inflammation.

The study, conducted mainly in mice and supported by the analysis of human skin data, has been published in the journal Nature Aging.

Journal: Nature Aging

Can antioxidant foods help prevent cervical cancer?

Wiley
Peer-Reviewed Publication

In research published in the International Journal of Gynecology & Obstetrics, a diet high in antioxidants was linked with a lower risk of cervical cancer in women.

Journal: International Journal of Gynecology & Obstetrics

Charles W.M. Roberts, MD, PhD, an internationally recognized physician-scientist, named president and CEO of St. Jude Children’s Research Hospital

St. Jude Children's Research Hospital
Business Announcement

Roberts has fostered collaborative, innovative partnerships across disciplines and institutions to accelerate progress against childhood cancer and other catastrophic diseases.

Lifesaving cancer treatment without life-threatening side effects

University of California - Irvine
Peer-Reviewed Publication

UC Irvine researchers highlight mitochondrial dysfunction as a promising target for reducing a serious neurological complication of CAR T-cell therapy in cancer patients.

The study outlines how existing drugs could be repurposed as safer alternatives to steroids in addressing this complication.

The research provides a road map for future clinical evaluation.

Journal: Frontiers in Pharmacology

T cells ditch exhaustion marker to escape tumors and protect against cancer relapse

University of Pittsburgh
Peer-Reviewed Publication

As the immune system battles cancer, chronic stimulation gradually drives T cells to a state of exhaustion. But some of these exhausted T cells can lose expression of the exhaustion marker LAG3, move out of the tumor, and confer long-lasting immunity to cancer in mice.

Journal: Journal of Experimental Medicine
Funder: Parker Institute for Cancer Immunotherapy

KTU chemists develop dual-action compounds to fight cancer and infections

Kaunas University of Technology
Peer-Reviewed Publication

In collaboration with partners, researchers at Kaunas University of Technology (KTU) have developed new hybrid compounds that, in laboratory studies, were shown to simultaneously reduce the viability of aggressive cancer cells and inhibit the growth of certain bacteria and fungi.

Journal: Scientific Reports

UT MD Anderson names 2026 Andrew Sabin Family Fellows

University of Texas M. D. Anderson Cancer Center
Grant and Award Announcement

The University of Texas MD Anderson Cancer Center today announced the newest class of Andrew Sabin Family Fellows, marking 102 fellows funded through this transformative philanthropic investment that provides support for emerging scientists and clinicians making breakthrough discoveries in cancer research and patient care.

βIII-tubulin in malignant tumors: unveiling its biological functions, mechanisms and roles in drug resistance

ELSP
Peer-Reviewed Publication

A recent review highlights the emerging role of βIII-tubulin (TUBB3) in cancer progression and therapeutic resistance. The study reveals how dysregulated TUBB3 alters microtubule dynamics, activates cancer-associated signaling pathways and reduces treatment sensitivity, while discussing its potential as a biomarker and therapeutic target for precision oncology.

Journal: Advanced Cancer Research

87
88
89
90
91